The Directorate for Medical Products warns of a shortage of the common cough suppressant solutions Cosylan and Solvipect comp in the coming months.
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.